Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle
Open Access

Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs

Vivian P. Bykerk, Pooneh Akhavan, Glen S. Hazlewood, Orit Schieir, Anne Dooley, Boulos Haraoui, Majed Khraishi, Sharon A. LeClercq, Jean Légaré, Diane P. Mosher, James Pencharz, Janet E. Pope, John Thomson, Carter Thorne, Michel Zummer and Claire Bombardier
The Journal of Rheumatology September 2011, jrheum.110207; DOI: https://doi.org/10.3899/jrheum.110207
Vivian P. Bykerk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pooneh Akhavan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Glen S. Hazlewood
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Orit Schieir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Dooley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boulos Haraoui
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Majed Khraishi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon A. LeClercq
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Légaré
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane P. Mosher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Pencharz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet E. Pope
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Thomson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carter Thorne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Zummer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Bombardier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters
Next
Loading

Abstract

Objective The Canadian Rheumatology Association (CRA) has developed recommendations for the pharmacological management of rheumatoid arthritis (RA) with traditional and biologic disease-modifying antirheumatic drugs (DMARD) in 2 parts. Part 1 is reported here.

Methods The CRA Therapeutics Committee assembled a national working group of RA clinical experts, researchers, patient consumers, and a general practitioner. Treatment questions were developed a priori based on results of a national needs assessment survey. A systematic review of all clinical practice guidelines and consensus statements regarding treatment with traditional and biologic DMARD in patients with RA published between January 2000 and June 2010 was performed in Medline, Embase, and CINAHL databases, and the grey literature. Guideline quality was assessed by 2 independent reviewers, and guideline characteristics, recommendations, and supporting evidence from observational studies and randomized controlled trials were synthesized into evidence tables. The full working group reviewed the evidence tables and developed recommendations using a modified Delphi technique.

Results Five overarching principles and 26 recommendations addressing general RA management strategies and treatment with glucocorticoids and traditional and biologic DMARD were developed for rheumatologists, other primary prescribers of RA drug therapies, and patients with RA.

Conclusion These recommendations were developed based on a synthesis of international guidelines, supporting evidence, and expert consensus considering the Canadian healthcare context with the intention of promoting best practices and improving healthcare delivery for persons with RA.

Next
Back to top

In this issue

The Journal of Rheumatology
Vol. 49, Issue 5
1 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs
Vivian P. Bykerk, Pooneh Akhavan, Glen S. Hazlewood, Orit Schieir, Anne Dooley, Boulos Haraoui, Majed Khraishi, Sharon A. LeClercq, Jean Légaré, Diane P. Mosher, James Pencharz, Janet E. Pope, John Thomson, Carter Thorne, Michel Zummer, Claire Bombardier
The Journal of Rheumatology Sep 2011, jrheum.110207; DOI: 10.3899/jrheum.110207

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs
Vivian P. Bykerk, Pooneh Akhavan, Glen S. Hazlewood, Orit Schieir, Anne Dooley, Boulos Haraoui, Majed Khraishi, Sharon A. LeClercq, Jean Légaré, Diane P. Mosher, James Pencharz, Janet E. Pope, John Thomson, Carter Thorne, Michel Zummer, Claire Bombardier
The Journal of Rheumatology Sep 2011, jrheum.110207; DOI: 10.3899/jrheum.110207
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Vasculitis: What Have We Learned in the Last 50 Years?
  • Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)–associated Bronchiectasis: Role of RA-related Autoantibodies
  • Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire